ROCKLAND, Mass., May 31, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, honors World MS Day 2017 by announcing a collaboration with the International Alliance of Carer Organizations (IACO) to launch the most comprehensive multiple sclerosis (MS) care partner survey to date.
The survey is being launched in response to preliminary findings from research commissioned by Merck KGaA, Darmstadt, Germany, which indicate that while 18 to 34-year-olds make up the largest group of MS care partners, the impact of caregiving during the prime of their lives and the challenges faced by this group are poorly understood. The global survey aims to provide a deep understanding of these unmet needs as a first step towards developing better resources and solutions for MS care partners in the future.
"We know that for many, providing care and support for someone with MS can be an overwhelming prospect – and this is particularly true for young people in the prime of their lives, building careers or families for example," said Rick Greene, Executive Advisor, International Alliance of Carer Organizations. "The findings from the research highlight the stark reality that faces many care partners in MS – anxiety, depression and pain being just a few. Therefore, in collaboration with Merck KGaA, Darmstadt, Germany, we are announcing a large-scale survey that will help us to build a comprehensive picture of the problems facing MS care partners and, importantly, look to develop solutions to address these needs."
Preliminary findings from research commissioned by Merck KGaA, Darmstadt, Germany showed the following:
"There are more than 2.3 million people with MS worldwide and between 350,000 and 500,000 people in the United States. MS affects their quality of life and that of caregivers, family and friends" said Peer Baneke, CEO of the MS International Federation. "This year's World MS Day campaign encourages anyone affected by MS to share their tips for managing the challenges of #LifeWithMS."
The global care partner survey, which is being launched on World MS Day and will be fielded in the following months, will uncover insights from care partners from the US, Europe, and Canada. Results from the survey will be announced in the next 12 months along with recommendations on how support can be shaped to address the needs of MS care partners, including younger care partners.
"EMD Serono is committed to improving understanding of the needs of MS patients and care partners to help inform our programs and initiatives," said Dr. Joseph Leveque, Chief Medical Officer, EMD Serono. "The global survey will help us identify new ways to support those affected by MS, including the families and friends of those with this overwhelming condition."
About Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, inflammatory condition of the central nervous system and is the most common, non-traumatic, disabling neurological disease in young adults. It is estimated that approximately 2.3 million people have MS worldwide. While symptoms can vary, the most common symptoms of MS include blurred vision, numbness or tingling in the limbs and problems with strength and coordination. The relapsing forms of MS are the most common.
About World MS Day 2017
World MS Day is officially marked on the last Wednesday of May. Events and campaigns take place throughout the month of May. It brings the global MS community together to share stories, raise awareness and campaign with and for everyone affected by multiple sclerosis.
In 2009, the MS International Federation (MSIF) MS International Federation (MSIF) and its members initiated the first World MS Day. Campaigns are rolled out globally which focus on a different theme each year. The theme for World MS Day 2017 is 'Life with MS'.
About the International Alliance of Carer Organizations (IACO)
Incorporated in 2012, the International Alliance of Carer Organizations (IACO) serves as an umbrella organization that provides cohesive direction, facilitates information sharing, and actively advocates for carers at an international level. IACO provides research, awareness and education regarding family carers on a global scale. By bringing visibility and an understanding of the growing numbers of carers worldwide, IACO facilities international collaboration by bringing together countries from around the globe that advocate for family carers.
About EMD Serono, Inc.
EMD Serono is the North America biopharma business of Merck KGaA, Darmstadt, Germany - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology as R&D focus areas. Today, the business has more than 1,100 employees around the country with commercial, clinical and research operations based in the company's home state of Massachusetts.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. The company holds the global rights to the "Merck" name and brand except in the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany, is one of the world's leading suppliers of effect pigments for the coatings, plastics, printing, cosmetic, food and pharmaceutical industries. Effect pigments underscore the emotional impact of color and are an important design element when creating surfaces with a special appearance or quality. Application possibilities range from cars to packaging and high-tech products up to building façades. In addition to decorative effect pigments, Merck KGaA, Darmstadt, Germany, offers pigments that also have functional applications such as heat-reflecting or anti-counterfeiting pigments.
Alice McGrail +1 781-681-2886
SOURCE EMD Serono